Chloroquine diphosphate
Showing 51 - 75 of 310
COVID-19 Trial in France (COVID 19 serology, COVID 19 Self-Questionnaire)
Recruiting
- COVID-19
- COVID 19 serology
- COVID 19 Self-Questionnaire
-
Limoges, France
- +11 more
Aug 31, 2021
Novel Coronavirus Infectious Disease (COVID-19) Trial (Carrimycin, lopinavir/ritonavir tablets or Arbidol or chloroquine
Unknown status
- Novel Coronavirus Infectious Disease (COVID-19)
- Carrimycin
- +2 more
- (no location specified)
Feb 25, 2020
COVID, Coronavirus Infection Trial in New York (Chloroquine, Placebo oral tablet)
Terminated
- COVID
- Coronavirus Infection
- Chloroquine
- Placebo oral tablet
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jan 10, 2022
Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)
Completed
- Metastatic Cancer
- Unspecified Adult Solid Tumor
- PARP inhibitor BMN-673
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 22, 2022
Malaria Trial in Worldwide (Pyronaridine artesunate, Chloroquine)
Completed
- Malaria
- Pyronaridine artesunate
- Chloroquine
-
Pailin, Pailin Province, Cambodia
- +4 more
Oct 22, 2021
HIV Trial in Roma (Antiviral Agents)
Not yet recruiting
- HIV Infections
- Antiviral Agents
-
Roma, ItalyFondazione PoliclinicoAgostino Gemelli IRCCS
Feb 9, 2023
HIV Prevention Trial in Los Angeles, Baltimore, Pittsburgh (Tenofovir enema, Saline enema)
Completed
- HIV Prevention
- Tenofovir enema
- Saline enema
-
Los Angeles, California
- +2 more
Jan 4, 2022
Obesity Trial in Basel (Placebo, Glucose, Monosodium glutamate)
Recruiting
- Obesity
- Placebo
- +3 more
-
Basel, SwitzerlandUniversity Hopital Basel
Oct 4, 2021
Ovarian Tumors Trial in United States (Niraparib, Bevacizumab)
Active, not recruiting
- Ovarian Neoplasms
- Niraparib
- Bevacizumab
-
Mobile, Alabama
- +27 more
Nov 23, 2022
Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)
Not yet recruiting
- Prostate Cancer
- Castrate Resistant Prostate Cancer
- Enzalutamide 40 MG
- Docetaxel injection
- (no location specified)
Jan 27, 2023
HIV/AIDS, HIV Prevention Trial in Baltimore (Tenofovir Douche)
Recruiting
- HIV/AIDS
- HIV Prevention
- Tenofovir Douche
-
Baltimore, MarylandJohns Hopkins University
Mar 7, 2022
Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents
Recruiting
- Human Immunodeficiency Virus (HIV)
- +2 more
- Observational PK study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Jun 13, 2022
Metabolic Syndrome X, Overweight, Hypertension Trial in Saint Louis (Chloroquine, Placebo Comparator)
Completed
- Metabolic Syndrome X
- +4 more
- Chloroquine
- Placebo Comparator
-
Saint Louis, MissouriWashington University School of Medicine
Dec 7, 2021
Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los
Recruiting
- Clear Cell Papillary Renal Neoplasm
- +10 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021
Through Self-collection of Dried Blood Spots
Recruiting
- Hiv
- Fingerstick collection of dried blood spots
-
Aurora, ColoradoUniversity of Colorado Health
Jul 16, 2021
Glioblastoma Trial in Cairo (Oral tablet, Placebo)
Active, not recruiting
- Glioblastoma
- Oral tablet
- Placebo
-
Cairo, EgyptPrivate clinics
Feb 25, 2021
Malaria, Vivax, G6PD Deficiency Trial in Mae Sot (primaquine, chloroquine + primaquine)
Terminated
- Malaria, Vivax
- G6PD Deficiency
- primaquine
- chloroquine + primaquine
-
Mae Sot, ThailandShoklo Malaria Research Unit (SMRU)
Oct 15, 2021
P Vivax, Malaria, Vivax Trial in Cruzeiro do Sul (Primaquine)
Completed
- P Vivax
- Malaria, Vivax
-
Cruzeiro do Sul, BrazilHospital do Jurua
Aug 5, 2021
Breast Cancer Trial in Worldwide (Neoadjuvant Olaparib monotherapy group, Neoadjuvant combination therapy with olaparib plus
Not yet recruiting
- Breast Cancer
- Neoadjuvant Olaparib monotherapy group
- Neoadjuvant combination therapy with olaparib plus durvalumab
-
Wien, Austria
- +6 more
Aug 10, 2022
Coronavirus, Corona Virus Infection Trial in New York (Group 1 HCQ, Group 2 Placebo)
Terminated
- Coronavirus
- Corona Virus Infection
- Group 1 HCQ
- Group 2 Placebo
-
New York, New YorkProHealth New York
Oct 15, 2021
Sars-CoV2, Symptomatic Condition, Covid-19 Trial in Lahore (Hydroxychloroquine Sulfate Regular dose, Hydroxychloroquine Sulfate
Terminated
- Sars-CoV2
- +2 more
- Hydroxychloroquine Sulfate Regular dose
- +3 more
-
Lahore, Punjab, Pakistan
- +3 more
Mar 8, 2021
Assess the Protocol for the COVID-19 Treatment in Burkina Faso
Completed
- Coronavirus Infection
-
Bobo-Dioulasso, Burkina Faso
- +1 more
Jan 21, 2021
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023